Pedex
Pedex
|
Boehringer Ingelheim
PUREVAX FeLV
Pedex
|
Boehringer Ingelheim
PUREVAX FeLV
PUREVAX® Recombinant FeLV contains a nonadjuvanted lyophilized suspension of a recombinant vectored feline leukemia vaccine plus sterile water diluent. A canarypox vector has been modified using recombinant technology to produce expression of desired antigens capable of stimulating a protective immune response to feline leukemia. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
Unique Technology Makes the Difference
- PUREVAX Recombinant FeLV is the first and only recombinant canarypox-vectored nonadjuvanted feline leukemia virus (FeLV) vaccine.
- PUREVAX FeLV provides efficacy equivalent to killed, adjuvanted FeLV vaccines.1
